Cross Country Healthcare, Inc. (NASDAQ:CCRN) shareholders might have a reason to worry after multiple insiders sold their shares over the last year.   When evaluating insider transactions, knowing whether insiders are buying versus if they selling is usually more beneficial, as the latter can be open to many interpretations.  However, if numerous insiders are selling, shareholders should investigate more.    

Although we don't think shareholders should simply follow insider transactions,  we would consider it foolish to ignore insider transactions altogether.

Cross Country Healthcare Insider Transactions Over The Last Year

The Executive VP & CFO, William Burns, made the biggest insider sale in the last 12 months. That single transaction was for US$321k worth of shares at a price of US$21.39 each.   While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price.  The silver lining is that this sell-down took place above the latest price (US$16.86).  So it may not shed much light on insider confidence at current levels.  

In the last year Cross Country Healthcare insiders didn't buy any company stock.    The chart below shows insider transactions (by companies and individuals) over the last year.  If you want to know exactly who sold, for how much, and when, simply click on the graph below!

NasdaqGS:CCRN Insider Trading Volume March 15th 2024

I will like Cross Country Healthcare better if I see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

Insiders At Cross Country Healthcare Have Sold Stock Recently  

The last quarter saw substantial insider selling of Cross Country Healthcare shares.  Specifically,   insider  Colin McDonald  ditched US$68k worth of shares in that time, and we didn't record any purchases whatsoever.  In light of this it's hard to argue that all the insiders think that the shares are a bargain.  

Insider Ownership

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders.  We usually like to see fairly high levels of insider ownership.   Cross Country Healthcare insiders own about US$34m worth of shares. That equates to 5.5% of the company.  This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.  

So What Do The Cross Country Healthcare Insider Transactions Indicate?

An insider  sold stock recently, but they haven't been buying.     And there weren't any purchases to give us comfort, over the last year.    While insiders do own shares, they don't own a heap, and they have been selling.  We're in no rush to buy!      In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Cross Country Healthcare.    At Simply Wall St, we've found that Cross Country Healthcare has 2 warning signs (1 makes us a bit uncomfortable!) that deserve your attention before going any further with your analysis.  

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.